[1] |
FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao.
Progress in treatment of gynecological cancer in 2023
[J]. China Oncology, 2024, 34(4): 340-360.
|
[2] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
[3] |
WANG Hui, WANG Xia, GAO Yi, XU Jing, YU Xiaojuan, FAN Fangqin, DING Yan, KANG Yu.
Current status and influencing factors of gene screening in first-degree relatives of patients with hereditary breast-ovarian cancer syndrome
[J]. China Oncology, 2023, 33(5): 499-505.
|
[4] |
ZHOU Changming, WANG Zezhou, ZHENG Ying.
Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China
[J]. China Oncology, 2023, 33(2): 117-125.
|
[5] |
XIA Lingfang, ZHU Jun, WU Xiaohua.
The latest progress and prospect of gynecological tumor treatment at 2023 ESMO
[J]. China Oncology, 2023, 33(11): 969-980.
|
[6] |
GUO Qinhao, YU Min, WU Xiaohua.
Progress in diagnosis and treatment of gynecological tumors in 2022
[J]. China Oncology, 2023, 33(1): 14-24.
|
[7] |
PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan.
Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2022, 32(6): 519-526.
|
[8] |
WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan.
Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016
[J]. China Oncology, 2022, 32(2): 97-105.
|
[9] |
FENG Zheng, WEN Hao.
Risk-reducing salpingo-oophorectomy for hereditary ovarian cancer
[J]. China Oncology, 2022, 32(11): 1044-1048.
|
[10] |
ZHAO Mingming, WANG Tianyou, WANG Chao.
Progress in menopausal hormone therapy for postoperative patients with gynecological malignant cancer
[J]. China Oncology, 2022, 32(11): 1098-1104.
|
[11] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[12] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[13] |
LU Ming, HONG Yuming, ZHENG Chaohui, CHEN Xiaofang, LIANG Zhenyuan.
Factors influencing postoperative hypercoagulability of free flap reconstruction for head and neck tumor
[J]. China Oncology, 2021, 31(4): 317-322.
|
[14] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[15] |
LIU Yixuan , WEN Zexuan , GUO Lin , LU Renquan .
The function of TTK1 in platinum-resistant ovarian cancer
[J]. China Oncology, 2021, 31(3): 182-191.
|